Vorinostat Terminated Phase 2 Trials for Mantle Cell Lymphoma (MCL) / Follicular Lymphoma (FL) / Marginal Zone Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01500538A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma